Skip to main content

DEXTROSE and SODIUM CHLORIDE 5 g/100mL / .2 g/100mL Medicare Part D Coverage

Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
93%
of Medicare Part D plans
cover DEXTROSE and SODIUM CHLORIDE
5,154 of 5,530 plans
3.1
Avg. formulary tier
$12.00
Median 30-day copay
$0.00–$24.00
Copay range

Formulary Tier Distribution

How Medicare Part D plans classify DEXTROSE and SODIUM CHLORIDE. Lower tiers = lower copays.

Tier 1 - Preferred Generic 5%
260 plans • avg $0.00/mo
Tier 2 - Generic 33%
1,719 plans • avg $2.10/mo
Tier 3 - Preferred Brand 12%
629 plans • avg $0.05/mo
Tier 4 - Non-Preferred Drug 49%
2,539 plans • avg $1.30/mo
Tier 6 - Select Care 0%
7 plans • avg $0.00/mo

Find the cheapest plan for DEXTROSE and SODIUM CHLORIDE

Enter your ZIP code to compare every plan in your area side-by-side.

Compare Plans for DEXTROSE and SODIUM CHLORIDE →

Get DEXTROSE and SODIUM CHLORIDE Delivered to Your Door

Compare prices and get discounts from trusted online pharmacies

DrugCovered may earn commissions from pharmacy purchases. Prices and availability vary. Always consult your doctor before starting or changing medications.

DEXTROSE and SODIUM CHLORIDE Medicare Coverage by State

Coverage rates and average costs vary significantly by state. Click a state to see the specific plans available there.

Frequently Asked Questions about DEXTROSE and SODIUM CHLORIDE

93% of Medicare Part D plans cover DEXTROSE and SODIUM CHLORIDE. It is most commonly placed on Tier 3. Coverage varies by plan and geographic area.

The median 30-day copay for DEXTROSE and SODIUM CHLORIDE on Medicare Part D is $12.00 at a preferred pharmacy. Costs range from $0.00 to $24.00 depending on the plan.

DEXTROSE and SODIUM CHLORIDE is placed on Tier 3 by most Medicare Part D plans. Lower tier numbers generally mean lower copays.

0% of plans require prior authorization for DEXTROSE and SODIUM CHLORIDE. Prior authorization means your doctor must confirm the drug is medically necessary before the plan will cover it.

Coverage statistics based on CMS formulary data for plan year 2026. Data updated regularly. Methodology →